Ethosuximide
Alternative Names: Suxinutin; Zarondan; ZarontinLatest Information Update: 25 Sep 2021
At a glance
- Originator Pfizer
- Class Antiepileptic drugs; Small molecules; Succinimides
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Absence epilepsy
Most Recent Events
- 21 Jun 2000 Warner-Lambert has merged with Pfizer
- 20 Oct 1997 Launched for Absence seizures in Australia (PO)
- 20 Oct 1997 Launched for Absence seizures in Canada (PO)